Forging a position as an innovative player in
infectious disease vaccines and therapies

About Our Disease Targets

We use our in-house expertise in development of therapeutics and in infectious disease plus our extensive partnership network to identify the best cost-effective commercial opportunities for portfolio value growth.

BioDiem’s development work currently focuses on the following key disease targets:

  • Influenza